Search Results 41-50 of 107 for ❤어코드주소 [원탑보증.com/가입코드 111] 보증업체 ❤

  2. Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors - Mayo Clinic

    Cabozantinib S-malate is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may ...

  3. Publications - Peter A. Noseworthy, M.D., M.B.A. - Mayo Clinic

    2024 Apr; 5 (2):111-114 Epub 2024 Feb 24. View PubMed; Christopoulos G, Attia ZI, Achenbach SJ, Rabe KG, Call TG, Ding W, Leis JF, Muchtar E, Kenderian SS ...

  4. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

    The primary objective is to evaluate whether macitentan 10 mg reduces N-terminal pro-brain natriuretic peptide (NT-pro-BNP) as compared to placebo in these ...

  5. Gonda Vascular Center in Minnesota - Overview - Mayo Clinic

    In addition, ballooning of the arteries causes aneurysm. This usually occurs in the main artery of the body (aorta), resulting in aortic aneurysms. Rupture of ...

  6. Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery - Mayo Clinic

    Vaccines consisting of heat shock protein-peptide complexes made from a person's own tumor tissue may help the body build an effective immune response to kill ...

  7. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence - Mayo Clinic

    A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated ...

  8. A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension - Mayo Clinic

    The purpose of this study is to evaluate the effect of sotatercept (ACE-011) in adults with Pulmonary Arterial Hypertension. Each eligible participant will ...

  9. Donate to Mayo Clinic

    With your support, we can continue providing top-notch patient care, groundbreaking research, and education to train the next generation of healthcare workers.

  10. Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD (VENT-AVOID) - Mayo Clinic

    A primary potential indication is for acute hypercapnic respiratory failure in patients experiencing an acute exacerbation of COPD. This study is being ...